Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Company
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Number of employees : 15 455 people.
Sales per Business
20202021Delta
Pharmaceutical1 300 840.00100%1 249 530.00100% -3.94%
JPY in Million
Sales per region
20202021Delta
United States443 455.0034.1%473 190.0037.9% +6.71%
Established Markets296 103.0022.8%293 156.0023.5% -1%
Japan345 402.0026.6%279 130.0022.3% -19.19%
International134 792.0010.4%111 113.008.9% -17.57%
Greater China60 367.004.6%59 300.004.7% -1.77%
Other20 725.001.6%33 639.002.7% +62.31%
JPY in Million
Managers
Name Title Age Since
Kenji Yasukawa President, CEO & Representative Director 61 2018
Naoki Okamura CFO, Representative Director & Vice President 59 2021
Yoshitsugu Shitaka Chief Scientific Officer - -
Fumiaki Sakurai Head-Business Administration & Compliance - -
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 65 2019
Nobue Yasuda Manager-Accounting - -
Nobuaki Tanaka Senior Executive Officer & General Manager-Sales 54 -
Claudia Mitchell, Dr. Senior VP-Product & Portfolio Strategy - 2019
Members of the board
Name Title Age Since
Yoshihiko Hatanaka Chairman 64 2018
Kenji Yasukawa President, CEO & Representative Director 61 2018
Naoki Okamura CFO, Representative Director & Vice President 59 2021
Tomokazu Fujisawa Director 63 2018
Hiroko Sakai Director 61 2018
Noriyuki Uematsu Outside Director 61 2018
Hiroo Sasaki Outside Director 65 2018
Mamoru Sekiyama Independent Outside Director 72 2017
Hiroshi Kawabe Independent Outside Director 69 2019
Tatsuro Ishizuka Independent Outside Director 65 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 1,861,787,075 1,842,108,206 98.9% 8,904,904 0.5% 98.9%
Shareholders
NameEquities%
Nomura Asset Management Co., Ltd. 112,101,000 6.02%
Wellington Management Co. LLP 96,092,754 5.16%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 63,322,700 3.40%
Nikko Asset Management Co., Ltd. 60,908,600 3.27%
BlackRock Fund Advisors 60,791,229 3.27%
Daiwa Asset Management Co. Ltd. 53,168,581 2.86%
Nippon Life Insurance Co. 53,036,000 2.85%
The Vanguard Group, Inc. 48,826,888 2.62%
Norges Bank Investment Management 30,885,860 1.66%
BlackRock Japan Co., Ltd. 28,854,100 1.55%
Holdings
NameEquities%Valuation
CYTOKINETICS, INCORPORATED (CYTK) 2,040,816 2.44% 71,244,887 USD
FIBROGEN, INC. (FGEN) 4,968,367 5.36% 55,248,241 USD
ASTELLAS PHARMA INC. (4503) 1,020,800 0.055% 17,161,792 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 1,199,819 4.92% 7,439,346 USD
ONCOLYS BIOPHARMA INC. (4588) 727,200 4.18% 3,922,190 USD
BRICKELL BIOTECH, INC. (BBI) 12,303 0.011% 4,860 USD
Markets and indexes
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- Bloomberg Code :  4503:JP
- Reuters Code :  4503.T
- Datastream Code :  
Company contact information
Astellas Pharma Inc.
2-5-1 Nihonbashi-Honcho
JP-103-8411 Chuo-ku, Tokyo

Phone : +81 3 3244 3000
Fax :
web site : http://www.astellas.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Astellas Pharma Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ASTELLAS PHARMA INC.14.46%29 699
JOHNSON & JOHNSON4.42%432 641
ROCHE HOLDING AG20.68%329 493
PFIZER, INC.39.64%288 501
NOVO NORDISK A/S73.12%256 630
ELI LILLY AND COMPANY45.17%221 499
ABBVIE INC.13.74%215 452
MERCK & CO., INC.-10.50%184 924
NOVARTIS AG-10.56%181 547
ASTRAZENECA PLC13.11%169 817
BRISTOL-MYERS SQUIBB COMPANY-7.14%127 852
SANOFI7.50%120 365
AMGEN INC.-7.13%120 274
GLAXOSMITHKLINE PLC18.61%105 486
CHUGAI PHARMACEUTICAL CO., LTD.-29.60%55 959
BAYER AG-5.02%50 931
JIANGSU HENGRUI MEDICINE CO., LTD.-45.78%50 572
DAIICHI SANKYO COMPANY, LIMITED-20.41%47 375
TAKEDA PHARMACEUTICAL COMPANY LIMITED-16.56%42 868
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY42.24%23 601
CATALENT, INC.22.48%21 820